XBIO
Xenetic Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$2.81
+0.24 ▲ +9.46%
🌙 3월 13일 7:12 PM ET (한국 3/14 08:12)
$2.70
-0.11 ▼ -3.85%
| Index | - | P/E | - | EPS (ttm) | -1.62 | Insider Own | 10.24% | Shs Outstand | 0.00B | Perf Week | 22.61% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | 31.2% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 9.99% | Short Float | 2.44% | Perf Quarter | 16.99% |
| Income | -0.00B | P/S | 2.16 | EPS this Y | - | Inst Trans | 2.37% | Short Ratio | 1.89 | Perf Half Y | -9.43% |
| Sales | 0.00B | P/B | 0.87 | EPS next 5Y | - | ROA | -35.12% | Short Interest | 0.05M | Perf YTD | 29.39% |
| Book/sh | 3.23 | P/C | 0.82 | EPS past 3/5Y | 30.07% 37.89% | ROE | -40% | 52W High | -79.84% ($13.93) | Perf Year | -17.18% |
| Cash/sh | 3.44 | P/FCF | - | Sales past 3/5Y | 20.36% 46.78% | ROIC | -36.25% | 52W Low | 47.77% ($1.90) | Perf 3Y | -19.18% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 22.7% | Gross Margin | - | Volatility(W/M) | 8.04% 7.89% | Perf 5Y | -89.08% |
| Dividend TTM | - | EV/Sales | -0.49 | Sales Y/Y TTM | 19.04% | Oper. Margin | -95.23% | ATR (14) | 0.19 | Perf 10Y | -99.76% |
| Dividend Ex-Date | - | Quick Ratio | 8.32 | EPS Q/Q | 63.03% | Profit Margin | -90.07% | RSI (14) | 65.03 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.32 | Sales Q/Q | 18.11% | SMA20 | 16.85% ($2.4) | Beta | 2.28 | Target Price | $40 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 20.31% ($2.34) | Rel Volume | 2.5 | Prev Close | $2.57 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 32.65% 63.02% | SMA200 | -6.37% ($3) | Avg Volume(3M) | 0.03M | Price | $2.81 |
| IPO | 2012/6/19 | Option/Short | No/Yes | Trades | 284 | Volume | 66,499 | Change | 9.46% |
뉴스 로딩 중...